Abstract
Cisapride, a gastrointestinal prokinetic agent, has been associated with cases of Torsades de Pointes but its effects on the cardiac action potential have not been described. We investigated its electrophysiological effects on rabbit isolated Purkinje fibres. The results demonstrated that cisapride (0.01-10 microM) lengthened concentration-dependently the action potential duration without modifying other parameters and induced early after depolarizations and subsequent triggered activity. This typical class III antiarrhythmic effect, that showed "reverse" rate-dependence and was reduced by increasing external K concentration, can account for clinical arrhythmogenesis.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adamantidis M. M., Lacroix D. L., Caron J. F., Dupuis B. A. Electrophysiological and arrhythmogenic effects of the histamine type 1-receptor antagonist astemizole on rabbit Purkinje fibers: clinical relevance. J Cardiovasc Pharmacol. 1995 Aug;26(2):319–327. doi: 10.1097/00005344-199508000-00019. [DOI] [PubMed] [Google Scholar]
- Antzelevitch C., Sicouri S. Clinical relevance of cardiac arrhythmias generated by afterdepolarizations. Role of M cells in the generation of U waves, triggered activity and torsade de pointes. J Am Coll Cardiol. 1994 Jan;23(1):259–277. doi: 10.1016/0735-1097(94)90529-0. [DOI] [PubMed] [Google Scholar]
- Bran S., Murray W. A., Hirsch I. B., Palmer J. P. Long QT syndrome during high-dose cisapride. Arch Intern Med. 1995 Apr 10;155(7):765–768. [PubMed] [Google Scholar]
- Hondeghem L. M., Snyders D. J. Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence. Circulation. 1990 Feb;81(2):686–690. doi: 10.1161/01.cir.81.2.686. [DOI] [PubMed] [Google Scholar]
- McCallum R. W., Prakash C., Campoli-Richards D. M., Goa K. L. Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders. Drugs. 1988 Dec;36(6):652–681. doi: 10.2165/00003495-198836060-00002. [DOI] [PubMed] [Google Scholar]
- Surawicz B. Electrophysiologic substrate of torsade de pointes: dispersion of repolarization or early afterdepolarizations? J Am Coll Cardiol. 1989 Jul;14(1):172–184. doi: 10.1016/0735-1097(89)90069-7. [DOI] [PubMed] [Google Scholar]